Lexicon Pharmaceuticals
LXRX
#7237
Rank
S$0.62 B
Marketcap
S$1.72
Share price
1.14%
Change (1 day)
76.15%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): S-$0.26

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.25. In 2024 the company made an earnings per share (EPS) of S-$0.83 an increase over its 2023 EPS that were of S-$1.03.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.26-69.13%
2024S-$0.83-20%
2023S-$1.0331.15%
2022S-$0.79-0%
2021S-$0.7910.91%
2020S-$0.71-145.08%
2019S$1.58-206.09%
2018S-$1.49-5.74%
2017S-$1.58-10.95%
2016S-$1.772640%
2015S-$0.06459-96.34%
2014S-$1.76-2.53%
2013S-$1.81-9.09%
2012S-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
S-$99.10 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$56.12-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.67 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$3.51-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$22.40-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.70 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.77-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.09-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.97 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA